Pharmaceutical Export Coordination — Chad
MHRA-Licensed, GDP-Aligned Pharmaceutical Exports Supporting Chad’s Regulated Import Systems
Chad’s healthcare procurement system incorporates public-sector import frameworks, regulated private distributors, and internationally supported health initiatives. All exports from GPD originate from our MHRA-licensed UK facility, with each stage operated under full Good Distribution Practice (GDP) governance. Our documentation aligns with the expectations of institutional oversight structures associated with the Direction de la Pharmacie, des Médicaments et des Laboratoires (DPML).
GDP-Structured Export Evidence Supporting Institutional Review
GPD prepares export documentation tailored for regulatory review and institutional audit processes, including: Batch and traceability verification, Packaging/seal integrity evidence, Temperature-monitoring logs validating thermal conditions. These records provide the clarity and traceability required in Chad’s import environment.
Arid-Climate Temperature Management
Validated thermal-control management designed for Chad’s hot and arid central and northern regions.
Arid-Climate Temperature Management
Validated thermal-control management designed for Chad’s hot and arid central and northern regions.
Calibrated Monitoring Devices
Calibrated temperature-monitoring devices ensure accurate tracking throughout the export process.
Verified Packaging Systems
Verified packaging systems maintain documented temperature stability during transit and handling.
Coordinated Export Processes for Public and Programme-Based Importers
Chad’s procurement channels include public institutions, regulated private importers, and international health-programme partners. GPD supports these pathways through structured communication, GDP-led export handling, and transparent documentation practices.
Governed Access to MHRA-Licensed Export Documentation
Authorised procurement bodies may request documentation via GPD’s compliance office for structured review.